Imagen de Portada

Spatial and Proteolytic Determinants of Therapeutic Potential in HER2‐Low Breast Cancer

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Deqian Xie, Wei Dai, Guangzhen Wu
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Advanced Science
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Proteogenomic Characterization Reveals Subtype‐Specific Therapeutic Potential for HER2‐Low Breast Cancer
por: Shouping Xu, et al.
Publicado: (2025)

NK Cell Activation by Platinum Boosts Immunotherapy in HR + /HER2 − Breast Cancer
por: Yi‐Yu Chen, et al.
Publicado: (2026)

Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
por: Changyong Guo, et al.
Publicado: (2024)

A Multifunctional Bimetallic Nanoplatform for Synergic Local Hyperthermia and Chemotherapy Targeting HER2‐Positive Breast Cancer
por: Li Zhao, et al.
Publicado: (2024)

A Dynamic Contrast‐Enhanced MRI‐Based Vision Transformer Model for Distinguishing HER2‐Zero, ‐Low, and ‐Positive Expression in Breast Cancer and Exploring Model Interpretability
por: Xu Zhang, et al.
Publicado: (2025)

Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer
por: Ningjun Duan, et al.
Publicado: (2024)

Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti‐Breast Cancer MCF7/HER2 Effects
por: Neni Frimayanti, et al.
Publicado: (2024)

Inactivated cGAS‐STING Signaling Facilitates Endocrine Resistance by Forming a Positive Feedback Loop with AKT Kinase in ER+HER2– Breast Cancer
por: Kai‐Ming Zhang, et al.
Publicado: (2024)

The Osteoblastic Microenvironment Determines the Fate of Breast Cancer Cells Disseminated in the Bone Marrow
por: Hong‐Li Wang, et al.
Publicado: (2026)

Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer
por: Jindong Xie, et al.
Publicado: (2025)

Engineering Bacteria as Living Therapeutics in Cancer Therapy
por: Jiangfeng Chen, et al.
Publicado: (2025)

Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
por: Qian Chen, et al.
Publicado: (2024)

Targeting the Hyperglycemic Pre‐Metastatic Niche to Prevent Breast Cancer Bone Metastasis: Mechanisms and Therapeutic Strategies
por: DuJiang Yang, et al.
Publicado: (2025)

3D‐Printed Breast Prosthesis that Smartly Senses and Targets Breast Cancer Relapse
por: Lu Wang, et al.
Publicado: (2024)

Universal Antibody‐Engineered Lipid Nanoparticles Potentiate Chemo‐Immunotherapy Against Triple‐Negative Breast Cancer by Reprogramming Tumor Cell Metabolism
por: Yeneng Dai, et al.
Publicado: (2026)

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer
por: Zhen Chen, et al.
Publicado: (2024)

SLC6A14 Drives Mitochondrial Fusion and Oxidative Phosphorylation to Promote Cancer Stemness and Early‐Onset of Breast Cancer
por: Dai‐Wei Hu, et al.
Publicado: (2025)

Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer
por: John D. Martin, et al.
Publicado: (2025)

Disruption of NF‐κB‐Mediated Copper Homeostasis Sensitizes Breast Cancer to Cuproptosis
por: Xiaomei Zhang, et al.
Publicado: (2025)

Dual‐Physical‐Field Nanocatalysis: Injectable Hydrogel Enables Piezo‐Photothermal Synergy for Breast Cancer Therapy
por: Can Tian, et al.
Publicado: (2026)

Artificial Intelligence for Predicting HER2 Status of Gastric Cancer Based on Whole‐Slide Histopathology Images: A Retrospective Multicenter Study
por: Yuhan Liao, et al.
Publicado: (2025)

Cobalt Single‐Atom Intercalation in Molybdenum Disulfide Enhances Piezocatalytic and Enzyodynamic Activities for Advanced Cancer Therapeutics
por: Haomiao Bai, et al.
Publicado: (2025)

3D‐Printed Breast Prosthesis that Smartly Senses and Targets Breast Cancer Relapse (Adv. Sci. 46/2024)
por: Lu Wang, et al.
Publicado: (2024)

Personalized Vascularized Models of Breast Cancer Desmoplasia Reveal Biomechanical Determinants of Drug Delivery to the Tumor (Adv. Sci. 38/2024)
por: Giovanni S. Offeddu, et al.
Publicado: (2024)

SF3A3 Drives Tumorigenesis in Endometrial Cancer by Enhancing c‐FOS Expression and Represents a Potential Therapeutic Target
por: Wei Yu, et al.
Publicado: (2025)

TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast Cancer
por: Xiuqing Lu, et al.
Publicado: (2024)

Integrating Spatial Proteogenomics in Cancer Research
por: Yida Wang, et al.
Publicado: (2026)

Near‐Infrared Afterglow Imaging‐Guided Surgical Resection and Synergistic Photodynamic‐Chemo Therapy of Breast Cancer
por: Zixuan Li, et al.
Publicado: (2025)

Living Therapeutics for Synergistic Hydrogen‐Photothermal Cancer Treatment by Photosynthetic Bacteria
por: Yingyi Zhang, et al.
Publicado: (2024)

Hydrophobicity Modulated Interfacial Water Distribution for Enhanced Kinetics of HER
por: Yucheng Dong, et al.
Publicado: (2026)

Alkaline Adjuvant Regulates Proteolytic Activity of Macrophages for Antigen Cross‐Presentation and Potentiates Radioimmunotherapy
por: Bei Li, et al.
Publicado: (2025)

Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets
por: Ganfei Xu, et al.
Publicado: (2024)

LncRNA FAISL Inhibits Calpain 2‐Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer
por: Yunmei Zhang, et al.
Publicado: (2024)

Artificial Intelligence for Predicting HER2 Status of Gastric Cancer Based on Whole‐Slide Histopathology Images: A Retrospective Multicenter Study (Adv. Sci. 10/2025)
por: Yuhan Liao, et al.
Publicado: (2025)

Replacing BPA: Structural Substitutes BPAF Binding to the Progesterone Receptor Elevates Breast Cancer Risk
por: Xiaotong Ji, et al.
Publicado: (2025)

Emerging Nanozyme Strategies for Precision Breast Cancer Treatment
por: Jian Zang, et al.
Publicado: (2025)

Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer (Adv. Sci. 14/2026)
por: John D. Martin, et al.
Publicado: (2026)

Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients
por: Danian Dai, et al.
Publicado: (2024)

Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment
por: Lam‐Duc‐Huy Nguyen, et al.
Publicado: (2025)

HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer
por: Xiaoniu He, et al.
Publicado: (2025)